Can Ursodeoxycholic Acid Prevent SARS-CoV-2 Infection or Reduce the COVID-19 Severity? Current Knowledge and Unresolved Issues
Abstract. A recent study revealed that the inhibition of the farnesoid X receptor using ursodeoxycholic acid (UDCA) significantly reduces angiotensin-converting enzyme 2 (ACE2) expression. Therefore, considerable attention has been paid to the use of UDCA to prevent severe acute respiratory syndrome...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer
2023-07-01
|
| Col·lecció: | Medicine |
| Accés en línia: | http://journals.lww.com/10.1097/ID9.0000000000000092 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|